Well, I assume it will remain heavily influenced by shorts as it has been forever, particularly if the price does rise between now and then. For me, Im keeping a very close eye on what happens to Botanix with FDA this week. If they get approved there is hope for Mesoblast. Bot had a CRL issued purely for the label on the box. They wanted it printed portrait instead of landscape, folded instead of wrapped, add " wash hand after use " to the bottle. Im not making this up.. FDA had months during the BLA to give them directions about how they wanted the label, and they still got a CRL, only for the label. Fast foreward 6 months and BOT have shared all the CRL points with shareholders , and changed the label and bottle writing, and done a human factors test that passed 100%. So on face value, its the most certain FDA approval Ive seen - Date set for 20th June ( 3 days ). I feel if BOT get another
CRL for a new label again..... then I have no hope for MSB... as it seems something else is actually going on at FDA. CRL for a label....... insanity...
- Forums
- ASX - By Stock
- Australian newspaper article
Well, I assume it will remain heavily influenced by shorts as it...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B |
Open | High | Low | Value | Volume |
$1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 24758 | $1.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.49 | 73626 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10033 | 1.485 |
4 | 53700 | 1.480 |
1 | 770 | 1.475 |
3 | 62048 | 1.460 |
1 | 50000 | 1.455 |
Price($) | Vol. | No. |
---|---|---|
1.490 | 21995 | 1 |
1.505 | 24000 | 1 |
1.510 | 13666 | 2 |
1.515 | 99798 | 1 |
1.520 | 27250 | 3 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
MSB (ASX) Chart |